PDCD1 and neoplasm: To further explain the relationship of PD-1 expression with the loss of important ILC2 anti-tumor properties in a more controlled setting, we intranasally (i.n.)challenged a cohort of WT mice with either rmIL-33 or PBS for three consecutive days (Figure 3A).